Gábor M.
- Country
- Hungary
- Department
- Endoszkópiai Laboratórium
Research Overview
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Phase 3 Randomized Double-Blind Placebo-Controlled Study of Tulisokibart Efficacy and Safety in Moderately to Severely Active Crohn's Disease
- Open-Label Extension Study Assessing Long-Term Safety of Etrasimod Arginine in Patients with Moderately to Severely Active Ulcerative Colitis
Data & Insights
Has run more than one trial at 183 of 310 partner sites.
Specializations
Inflammatory Bowel Disease
The investigator concentrates on therapeutic strategies for Inflammatory Bowel Disease aiming at sustained remission and mucosal healing.
- Crohn's disease
- Ulcerative colitis
- Endoscopic response
- Stool frequency
- Abdominal pain
Clinical work includes evaluation of biologics and oral small‑molecule agents in induction and maintenance phases.
Dermatology – Atopic Dermatitis and Psoriasis
Research addresses moderate to severe Atopic Dermatitis and Plaque Psoriasis with emphasis on efficacy and safety of systemic and topical regimens.
- Atopic dermatitis
- Plaque psoriasis
- Eczema Area and Severity Index
- Topical corticosteroids
- Systemic therapy
Long‑term follow‑up studies evaluate dose optimisation and quality‑of‑life outcomes.
Neuropsychiatric Disorders
Activities focus on neuropsychiatric manifestations of Alzheimer’s disease and related conditions.
- Alzheimer’s disease
- Psychosis
- Agitation
- Major depressive disorder
- Schizophrenia
- Hallucinations and delusions
Investigations include adjunctive therapies and measures of cognitive and behavioral improvement.
Cardiovascular and Metabolic Health
The investigator explores interventions for Atrial Fibrillation and Heart Failure within broader cardiovascular risk management.
- Atrial fibrillation
- Heart failure with reduced ejection fraction
- Atherosclerotic cardiovascular disease
- Obesity
- Stroke prevention
Research evaluates anticoagulation alternatives and metabolic therapies aimed at reducing morbidity and mortality.
Respiratory Medicine
Work is directed toward disease‑modifying approaches for chronic obstructive pulmonary disease.
- Chronic obstructive pulmonary disease
- Exacerbations
- Airway inflammation
- Long‑term safety
Studies integrate novel biologic agents with standard inhaled therapies to reduce exacerbation rates.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.